Target intelligence / Profile preview

p53-mediated lysosome–mitochondria apoptosis signaling pathway (null)

Target
null
Molecular classification
Other (specifically: apoptosis signaling pathway)
01

Overview

The p53-mediated lysosome–mitochondria apoptosis signaling pathway describes a sequence of molecular events by which the tumor suppressor protein p53 initiates programmed cell death. Upon cellular stress (such as DNA damage), p53 activation causes destabilization of lysosomal membranes, releasing proteases that damage mitochondria. Subsequent mitochondrial outer membrane permeabilization leads to the release of apoptogenic factors such as cytochrome c, eventually activating caspases and leading to apoptosis. This pathway plays a major role in tumor suppression by eliminating damaged or potentially cancerous cells. In cancer, dysregulation of p53 or components of this pathway frequently leads to resistance to cell death and tumor progression.

Other names
p53-induced lysosomal-mitochondrial pathwayp53-dependent lysosomal pathway of apoptosis
02

Mechanism of action

Not applicable to the pathway as a whole, but drugs that induce p53 activity (by causing DNA damage) can trigger this pathway, leading to cell death via lysosomal destabilization and mitochondrial permeabilization.

03

Biological functions

ApoptosisCell deathStress responseTumor suppression
04

Disease associations

Cancer (especially tumor suppression)Neurodegenerative disease (by analogy with apoptosis regulation; not direct evidence here)Other diseases involving deregulated apoptosis (speculative, beyond explicit search results)
05

Safety considerations

As this is not a drug target, direct safety concerns are not applicable; however, excessive activation of this pathway can cause unwanted cell death in normal tissues (potential toxicity in cancer therapy targeting p53/apoptosis)
06

Interacting drugs

doxorubicin

2 more in the full profile.

07

Biomarkers

Lysosomal membrane permeabilization (LMP)Mitochondrial membrane potential changesCytochrome c releaseCaspase activationp53 status in tumor cells

Beyond the preview

Go deeper on p53-mediated lysosome–mitochondria apoptosis signaling pathway (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on p53-mediated lysosome–mitochondria apoptosis signaling pathway (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call